Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel
- PMID: 28098529
- PMCID: PMC5324804
- DOI: 10.3201/eid2302.161486
Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel
Abstract
Candida auris and C. haemulonii are closely related, multidrug-resistant emerging fungal pathogens that are not readily distinguishable with phenotypic assays. We studied C. auris and C. haemulonii clinical isolates from 2 hospitals in central Israel. C. auris was isolated in 5 patients with nosocomial bloodstream infection, and C. haemulonii was found as a colonizer of leg wounds at a peripheral vascular disease clinic. Liberal use of topical miconazole and close contact among patients were implicated in C. haemulonii transmission. C. auris exhibited higher thermotolerance, virulence in a mouse infection model, and ATP-dependent drug efflux activity than C. haemulonii. Comparison of ribosomal DNA sequences found that C. auris strains from Israel were phylogenetically distinct from isolates from East Asia, South Africa and Kuwait, whereas C. haemulonii strains from different countries were closely interrelated. Our findings highlight the pathogenicity of C. auris and underscore the need to limit its spread.
Keywords: Candida auris; Candida haemulonii; Israel; antimicrobial resistance; bloodstream infection; fungi; virulence.
Figures




Similar articles
-
Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.J Clin Microbiol. 2015 Jun;53(6):1823-30. doi: 10.1128/JCM.00367-15. Epub 2015 Mar 25. J Clin Microbiol. 2015. PMID: 25809970 Free PMC article.
-
Comparative analyses of the biological characteristics, fluconazole resistance, and heat adaptation mechanisms of Candida auris and members of the Candida haemulonii complex.Appl Environ Microbiol. 2025 Apr 23;91(4):e0240624. doi: 10.1128/aem.02406-24. Epub 2025 Mar 26. Appl Environ Microbiol. 2025. PMID: 40135859 Free PMC article.
-
The emerging pathogen Candida auris: A focus on the Middle-Eastern countries.J Infect Public Health. 2019 Jul-Aug;12(4):451-459. doi: 10.1016/j.jiph.2019.03.009. Epub 2019 Apr 16. J Infect Public Health. 2019. PMID: 31000491 Review.
-
Multidrug-resistant endemic clonal strain of Candida auris in India.Eur J Clin Microbiol Infect Dis. 2014 Jun;33(6):919-26. doi: 10.1007/s10096-013-2027-1. Epub 2013 Dec 20. Eur J Clin Microbiol Infect Dis. 2014. PMID: 24357342
-
Candida auris, what do paediatricians need to know?Arch Dis Child. 2018 Sep;103(9):891-894. doi: 10.1136/archdischild-2017-313960. Epub 2018 Mar 15. Arch Dis Child. 2018. PMID: 29545411 Free PMC article. Review.
Cited by
-
Metabolic profiling of Candida clinical isolates of different species and infection sources.Sci Rep. 2020 Oct 7;10(1):16716. doi: 10.1038/s41598-020-73889-1. Sci Rep. 2020. PMID: 33028931 Free PMC article.
-
The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens.J Fungi (Basel). 2020 Aug 18;6(3):138. doi: 10.3390/jof6030138. J Fungi (Basel). 2020. PMID: 32824785 Free PMC article. Review.
-
Candida haemulonii: An emerging opportunistic pathogen in the United States?IDCases. 2020 Jul 2;21:e00900. doi: 10.1016/j.idcr.2020.e00900. eCollection 2020. IDCases. 2020. PMID: 32685371 Free PMC article.
-
Functional Expression of Recombinant Candida auris Proteins in Saccharomyces cerevisiae Enables Azole Susceptibility Evaluation and Drug Discovery.J Fungi (Basel). 2023 Jan 27;9(2):168. doi: 10.3390/jof9020168. J Fungi (Basel). 2023. PMID: 36836283 Free PMC article.
-
Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.Antimicrob Agents Chemother. 2018 May 25;62(6):e00238-18. doi: 10.1128/AAC.00238-18. Print 2018 Jun. Antimicrob Agents Chemother. 2018. PMID: 29632013 Free PMC article.
References
-
- Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al.; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370:1198–208. 10.1056/NEJMoa1306801 - DOI - PMC - PubMed
-
- Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, et al.; Mycoses Study Group. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54:1110–22. 10.1093/cid/cis021 - DOI - PubMed
-
- Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis. 2013;56:1724–32. 10.1093/cid/cit136 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical